title: Comment to the paper: The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma : Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek.
authors.affiliation: Skeptics for the Protection of Cancer Patients, PO Box 484, Chippewa Falls, WI, 54729, USA, rjblaskiewicz@gmail.com.
authors.forename: Robert
authors.initials: R
authors.lastname: Blaskiewicz
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D044482:Benzeneacetamides / Q000627:therapeutic use*; D020295:Brain Stem Neoplasms / Q000188:drug therapy*; D005260:Female; D005910:Glioma / Q000188:drug therapy*; D005973:Glutamine / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D010648:Phenylacetates / Q000627:therapeutic use*; D010881:Piperidones / Q000627:therapeutic use*; D011149:Pons
chemical_list: D044482:Benzeneacetamides; D010648:Phenylacetates; D010881:Piperidones; D005973:Glutamine